Cprx stock forecast

2 Wall Street research analysts have issued 1-yea

According to our current CPRX stock forecast, the value of Catalyst Pharmaceuticals shares will drop by -8.79% and reach $ 12.82 per share by December 5, 2023. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceFind the latest Earnings Report Date for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.

Did you know?

About the IonQ Inc stock forecast. As of 2023 December 04, Monday current price of IONQ stock is 13.610$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). IonQ stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given ...VOD Stock 12 Months Forecast. $14.45. (52.11% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Vodafone in the last 3 months. The average price target is $14.45 with a high forecast of $14.45 and a low forecast of $14.45. The average price target represents a 52.11% change from the last price of $9.50.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Nov 30, 2023 · Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CPRX stock stock is $23.75, which predicts an increase of 64.59%. The lowest target is $20 and the highest is $27. On average, analysts rate CPRX stock stock as a strong buy. The highest forecast stands at $28.00, while the lowest forecast is $14.00. Overall, the analyst rating consensus for ImmunoGen is a Strong Buy, based on the assessments of 8 Wall Street analysts. Examining ImmunoGen’s stock price history, it stood at $29.35 at the time of the report.Use our graph to track the performance of CPRX stocks over time. Share price volatility. Over the last 12 months, Catalyst Pharmaceuticals's shares have ranged ...About the Catalyst Pharmaceuticals, Inc. stock forecast. As of 2023 November 26, Sunday current price of CPRX stock is 14.060$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Catalyst Pharmaceuticals stock price has been showing a declining tendency so we believe that …Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.VOD Stock 12 Months Forecast. $14.45. (52.11% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Vodafone in the last 3 months. The average price target is $14.45 with a high forecast of $14.45 and a low forecast of $14.45. The average price target represents a 52.11% change from the last price of $9.50.Use our graph to track the performance of CPRX stocks over time. Share price volatility. Over the last 12 months, Catalyst Pharmaceuticals's shares have ranged ...Earnings vs Savings Rate: CPRX's forecast earnings growth (25.8% per year) is above the savings rate (2.2%). Earnings vs Market: CPRX's earnings (25.8% per year) are forecast to grow faster than the US market (14.7% per year). High Growth Earnings: CPRX's earnings are expected to grow significantly over the next 3 years.7 brokerages have issued 12-month price targets for Cross Country Healthcare's shares. Their CCRN share price targets range from $21.00 to $40.00. On average, they anticipate the company's share price to reach $27.50 in the next year. This suggests a possible upside of 34.7% from the stock's current price.DHT Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for DHT Holdings in the last 3 months. The average price target is $12.93 with a high forecast of $15.00 and a low forecast of $11.00. The average price target represents a 16.59% change from the last price of $11.09.According to . 3 Wall Street analysts that have issued a 1 year CPRX price target, the average CPRX price target is $25.00, with the highest CPRX stock price forecast at $27.00 and the lowest CPRX stock price forecast at $24.00.Currently 11 wall-street analysts regularly analyze the financials of Catalyst Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 11 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc (CPRX) have a share price target of $23.1.Find the latest analyst research for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) ... Forecast Changes; ... Analysts evaluate the stock’s expected performance in a given time ...TSE Stock 12 Months Forecast. $11.60. (70.59% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Trinseo in the last 3 months. The average price target is $11.60 with a high forecast of $23.00 and a low forecast of $7.00. The average price target represents a 70.59% change from the last price of $6.80.14 Days Historical Data CPRX : Catalyst Pharmaceuticals stock forecast by Wall Street Analysts The average Catalyst Pharmaceuticals stock forecast from last 6 month is …Find real-time TCRT - Alaunos Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.In the last 12 months, CPRX had revenue of $348.39 million and earned $62.04 million in profits. Earnings per share was $0.53. Revenue. 348.39M. Gross Profit. 301.04M. Operating Income. 75.92M. Pretax Income.Mar 31, 2023 · CPRX, CALM, and NJR vs. S&P 500 Stock Price Forecast. The 1 analysts offering 12-mon Analyst Future Growth Forecasts Earnings vs Savings Rate: CPRX's forecast earnings growth (25.8% per year) is above the savings rate (2.2%). Earnings vs …Find real-time VTRS - Viatris Inc stock quotes, company profile, news and forecasts from CNN Business. Meta Materials Inc. (NASDAQ:MMAT) released its earning TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com Price target in 14 days: 15.512 USD. The best

SWN Stock 12 Months Forecast. $8.53. (27.98% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Southwestern Energy in the last 3 months. The average price target is $8.53 with a high forecast of $15.00 and a low forecast of $5.50. The average price target represents a 27.98% change from the last price of $6.67.CPRX Stock Forecast: Bull Case. Targeting Rare Disease LEMS – Lambert Eaton myasthenic syndrome (LEMS) is a condition of immune system attacking neuromuscular junctions- where nerves and muscles meet and is associated with small cell lung cancer. It hit the market in 2019.Check price target & stock forecast for Catalyst here>>> While the ABR calls for buying Catalyst, it may not be wise to make an investment decision solely based on this information.Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceCPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.

Catalyst Pharmaceuticals Q3 Adjusted Profit, Revenue Rise; Lifts 2023 Guidance. Nov. 09. MT. Earnings Flash (CPRX) CATALYST PHARMACEUTICALS Reports Q3 EPS $0.49. Nov. 08. MT. Earnings Flash (CPRX) CATALYST PHARMACEUTICALS Posts Q3 Revenue $102.7M, vs. Street Est of $100.4M. Nov. 08. …Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Catalyst Pharmaceuticals Inc. 12.79. Delayed Data. As of Oct 13. +0.075 / +0.59%. Today’s Change. 11.09. Today ||| 52-Week ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. 8 dni temu ... Stock market news today: Stocks close with ga. Possible cause: SWN Stock 12 Months Forecast. $8.53. (27.98% Upside) Based on 13 Wall Street analysts off.

The Zacks Analyst Blog Highlights Gilead Sciences, Legend Biotech, BeiGene, Exact Sciences and Sarepta Therapeutics. Nov 21 / Zacks.com - Paid Partner Content. 2 Revolutionary Stocks That Could ...Find real-time EXAS - Exact Sciences Corp stock quotes, company profile, news and forecasts from CNN Business.

According to our current CPRX stock forecast, the value of Catalyst Pharmaceuticals shares will drop by -8.79% and reach $ 12.82 per share by December 5, 2023. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear). CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.

REAL Stock 12 Months Forecast. $4.25. (101.90% Upside Regeneron Pharmaceuticals Inc Fair Value Forecast for 2023 - 2025 - 2030. In the last three years, Regeneron Pharmaceuticals Inc's Price has seen an increase, rising from $376.22 to $685.95. This represents a growth of 82.33%. Analysts predict that Regeneron Pharmaceuticals Inc's Fair Value will increase in the upcoming year, reaching $700.43. DHT Stock 12 Months Forecast. Based on 4 Wall Street analysts offerFind the latest Catalyst Pharmaceuticals, Nov 24, 2023 · Income Statement. In the last 12 months, CPRX had revenue of $348.39 million and earned $62.04 million in profits. Earnings per share was $0.53. Revenue. 348.39M. Gross Profit. 301.04M. Operating Income. 75.92M. VOD Stock 12 Months Forecast. $14.45. (52.11% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Vodafone in the last 3 months. The average price target is $14.45 with a high forecast of $14.45 and a low forecast of $14.45. The average price target represents a 52.11% change from the last price of $9.50. Stock Price Forecast. The 10 analysts offering 12-month price forecast Company Summary. Coral Gables, FL-based Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, focused on the development and commercialization of therapies targeting rare ... Find real-time TSP - TuSimple Holdings Inc stock quotes, company prNov 17, 2023 · The latest Catalyst PharmaceOct 12, 2023 · Find the latest Catalyst Pharmaceuticals, Inc. (CPRX Find the latest Compugen Ltd. (CGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. https://www.catalystpharma.com. Catalyst Pharma Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile. Find real-time YPF - YPF SA stock quotes, company profile, news a[What this means: InvestorsObserver gives CatalStock Price Forecast. The 5 analysts offering 12-m 8 brokers have issued 1-year price objectives for RealReal's stock. Their REAL share price targets range from $1.85 to $6.00. On average, they predict the company's stock price to reach $3.45 in the next twelve months. This suggests a possible upside of 55.4% from the stock's current price. View analysts price targets for REAL or view top-rated ...